Approaches to Processing SARS-CoV-2 Samples for RNA Detection

Discover new RNA extraction and purification strategies and how they enable reliable and sensitive viral detection.

The Scientist Creative Services Team in collaboration with MilliporeSigma
May 10, 2021

FREE Webinar

Wednesday, June 16, 2021
11:00 AM - 12:30 PM, Eastern Time

Register Now

The COVID-19 pandemic emphasized the need for access to reliable and cost-effective virus detection. Virus detection techniques typically look for nucleic acids within samples, using protocols designed to isolate viral RNA for downstream nucleic acid detection and analysis. Scientists can either adapt previously established RNA extraction techniques for viral samples or develop new strategies and reagents centered on viral RNA extraction. In this webinar, brought to you by MilliporeSigma, Nicolas Caffarelli and Kan Saito will describe how previously developed RNA extraction kits can be optimized and validated for easy, sensitive viral RNA purification and detection. They will also highlight recently developed reagents, including a novel viral RNA extraction buffer that can be mixed directly with virus-containing sample, allowing for rapid room-temperature lysis and RNA detection without the need for further clean up.

Topics to be covered

  • Column-based viral RNA extraction strategies
  • Rapid direct viral lysis for RNA detection
  • qRT-PCR kits compatible with sensitive SARS-CoV-2 detection

Register Now

Meet the Speakers:

Nicolas Caffarelli
R&D Senior Scientist
MilliporeSigma


Kan Saito, PhD
R&D Scientist
MilliporeSigma


The life science business of Merck KGaA, Darmstadt, Germany operates as MilliporeSigma in the U.S. and Canada